What are the stages of iron toxicity in a pediatric patient under 6 years old with suspected iron overdose?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 27, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Stages of Iron Toxicity in Pediatric Patients

Iron toxicity in children under 6 years progresses through five distinct clinical stages, with the most critical being Stage II (latent phase) which can falsely reassure clinicians before life-threatening Stage III develops.

Stage I: Gastrointestinal Phase (0-6 hours post-ingestion)

  • Direct corrosive injury to the GI mucosa causes vomiting, diarrhea, abdominal pain, and hematemesis 1, 2
  • Symptoms occur within the first 6 hours and reflect local tissue damage from free iron 1
  • Severe or persistent vomiting and bloody diarrhea indicate significant toxicity requiring immediate referral 2
  • Hyperglycemia and leukocytosis may develop as early metabolic markers 1

Critical Pitfall: Mild vomiting and diarrhea are common and do not necessarily warrant hospital referral if the ingested dose is <40 mg/kg elemental iron 2. However, persistent or severe symptoms always require evaluation.

Stage II: Latent Phase (6-24 hours post-ingestion)

  • This deceptively quiescent period represents the most dangerous phase because symptoms may temporarily resolve while cellular toxicity progresses 1
  • Free iron continues to cause mitochondrial dysfunction and cellular damage despite apparent clinical improvement 1
  • Asymptomatic patients beyond 6 hours post-ingestion are unlikely to develop subsequent toxicity and may not require prolonged observation 2

Critical Pitfall: Clinicians may discharge patients during this phase, missing the window for intervention before cardiovascular collapse occurs 1.

Stage III: Shock and Metabolic Acidosis (12-48 hours post-ingestion)

  • Cardiovascular collapse with profound shock develops from mitochondrial poisoning and vasodilation 1, 3
  • Severe anion gap metabolic acidosis results from lactic acid accumulation and iron-induced metabolic dysfunction 4, 1
  • Altered mental status progressing to coma indicates severe toxicity 4, 1
  • Coagulopathy develops as hepatic synthetic function fails 5

Management at this stage requires:

  • Aggressive fluid resuscitation and vasopressor support 1, 3
  • Immediate deferoxamine chelation therapy 4, 1
  • Consideration of hemodialysis for massive overdoses with serum iron >2000 mcg/dL 4

Stage IV: Hepatotoxicity (2-5 days post-ingestion)

  • Fulminant hepatic failure manifests with elevated transaminases, coagulopathy, and encephalopathy 5
  • Hepatocellular necrosis results from direct iron toxicity to hepatocytes 1, 5
  • Presence of coagulopathy and acute liver failure are associated with high mortality in pediatric patients 5
  • Plasmapheresis may be considered for severe cases, though evidence is limited 5

Stage V: Gastric Outlet Obstruction (2-8 weeks post-ingestion)

  • Late complication from scarring and stricture formation at sites of corrosive injury 1
  • Presents with persistent vomiting and feeding intolerance weeks after apparent recovery 1
  • Requires endoscopic evaluation and potential surgical intervention 1

Dose-Based Risk Stratification

The following thresholds guide initial management decisions:

  • <40 mg/kg elemental iron: Home observation with follow-up if asymptomatic or mild symptoms only 2
  • ≥40 mg/kg elemental iron: Immediate referral to healthcare facility regardless of symptoms 2
  • >60 mg/kg elemental iron: Potentially serious toxicity requiring aggressive intervention 1

Special considerations for young infants:

  • Premature infants and neonates face additional challenges from physiologic immaturity of developing organs 3
  • Even standard therapeutic iron supplementation errors can cause severe toxicity in this age group 3
  • Include toxic iron exposure in the differential diagnosis of unexplained neonatal shock 3

Key Clinical Indicators of Severe Toxicity

Immediate hospital referral is mandatory for:

  • Persistent or severe vomiting and diarrhea 2
  • Hematemesis or bloody diarrhea 2
  • Altered level of consciousness 2
  • Metabolic acidosis 4, 1
  • Shock or cardiovascular instability 1, 3
  • Coagulopathy 5

Radiographic findings:

  • Abdominal X-ray may reveal radiopaque tablets in the GI tract, confirming significant ingestion 1
  • Presence of iron concretions indicates need for whole-bowel irrigation 1

References

Research

Management of acute iron overdose.

Clinical pharmacy, 1989

Research

Infantile iron poisoning: challenges in diagnosis and management.

Pediatric critical care medicine : a journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies, 2009

Research

Accidental iron poisoning in children - Experience from a teaching institution.

Journal of family medicine and primary care, 2023

Related Questions

What is the toxic dose of iron (Fe) in children?
What should I do if a 3-year-old child ingested an iron supplement and now has diarrhea?
In whom does iron toxicity occur?
What is the lethal dose of iron (Fe) poisoning in pediatric and adult patients?
What is the appropriate management for a pediatric patient with acute iron poisoning?
What are alternative treatments for a patient with a complicated urinary tract infection (UTI) aside from Ceftriaxone?
What is the CHADS2 (Congestive heart failure, Hypertension, Age ≥ 75 years, Diabetes mellitus, Stroke or transient ischemic attack) score for a patient with atrial fibrillation, congestive heart failure, hypertension, diabetes mellitus, and a history of stroke, presenting with dyspnea, shortness of breath, palpitations, irregular pulse, high jugular venous pressure (JVP), S3 heart sound, bi-basal crackles, tachycardia, and hypoxemia?
What is the management of a patient with thyrotoxicosis (a condition characterized by excessive levels of thyroid hormones) complicated by shock?
What is the best management plan for a 64-year-old female patient, ex-smoker, with a history of malignant melanoma, lentigo maligno, and adenopathy, who refuses exenteration ocular and has multiple comorbidities?
What is the CHADS2 (Congestive heart failure, Hypertension, Age ≥ 75 years, Diabetes mellitus, Stroke or transient ischemic attack) score for a patient with atrial fibrillation, congestive heart failure, hypertension, diabetes mellitus, and a history of stroke, presenting with dyspnea, shortness of breath, palpitations, irregular pulse, high jugular venous pressure (JVP), S3 heart sound, bi-basal crackles, tachycardia, and hypoxemia?
Is megestrol (a progestin) a suitable treatment option for a patient experiencing heavy vaginal bleeding?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.